Tennessee Department of Health Statement on Johnson & Johnson VaccineFDA and CDC recommend pausing administration of vaccine
NASHVILLE - The Tennessee Department of Health is acting upon recent guidance from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) to pause administration of the Johnson & Johnson COVID-19 vaccine. Our vaccine supply continues to surpass demand and we do not anticipate this shift will impact our efforts to vaccinate as many Tennesseans as possible. We continue to monitor the situation closely.
While the reports of serious adverse events after the administration of the Johnson & Johnson vaccine are rare, six cases out of nearly 7 million doses administered, TDH is taking necessary precautions and is coordinating with our vaccine providers that may have the Johnson & Johnson vaccine in supply to ensure those in our state who are seeking a vaccine have access to vaccines manufactured by Pfizer or Moderna. Both vaccines are highly effective at preventing COVID-19 after 14 days from the second vaccine dose. Both doses are required to achieve the best protection against the virus that causes COVID-19.
The mission of the Tennessee Department of Health is to protect, promote and improve the health and prosperity of people in Tennessee. TDH has facilities in all 95 counties and provides direct services for more than one in five Tennesseans annually as well as indirect services for everyone in the state, including emergency response to health threats, licensure of health professionals, regulation of health care facilities and inspection of food service establishments. Learn more about TDH services and programs at www.tn.gov/health.